tirzepatide and retatrutide together vs Tirzepatide: What the Triple Agonist Era Means (2026) Retatrutide vs. Tirzepatide: GLP-1 Research

Patients with the following conditions should avoid FDA-approved semaglutide products: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Severe allergic reactions to semaglutide History of pancreatitis Diabetic retinopathy Kidney problems Serious stomach issues Pregnancy or breastfeeding Compounded semaglutide , lacking FDA approval, does not have the same established safety guidelines or defined patient populations

While Wegovy is generally favored due to its higher dosing range, the choice between the two depends on individual needs and a healthcare providers recommendation

Your healthcare professional will show you how to measure and inject the correct dose of tirzepatide

Persistent fatigue Emotional stress Increased appetite Compromised mobility Low mood/anxiety Difficulty with weight regulation Low self-esteem Sleep disturbances Starting at $99 99 /mo (Paid Annually) Starting at $144 97 /mo (Paid Annually) Weekly subcutaneous injection Weekly subcutaneous injection Weekly subcutaneous injection .25mg up to 2.5mg per dose 2.5mg up to 15mg per dose .25mg up to 2.5mg per dose Access to discounted peptide therapies & natural supplements